The move, limited to acne medications, sets the stage for a new era in healthcare in which AI takes on a larger role in routine medical care.
SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75. The Offer was initially scheduled to expire at 5:00 p.
SALT LAKE CITY, UT / ACCESS Newswire / September 25, 2026 / (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC athttps://www.
Utah Medical Products Inc (NASDAQ:UTMD) recently announced a total dividend of $0.31 per share. The ex-dividend date is set for 2026-09-17, and the cash dividend of $0.31 per share is payable on 2026-10-05. For investors, the ex-dividend date is the cutoff: shareholders must own the stock before this date to qualify for the payment, while the paydate marks when the cash actually arrives.
Detailed price information for Utah Medical Prod (UTMD-Q) from The Globe and Mail including charting and trades.
SALT LAKE CITY, UT / ACCESS Newswire / August 31, 2026 / Femcare Ltd. ("Femcare"), a wholly-owned subsidiary of (Nasdaq:UTMD), announces that it has purchased the entire ordinary share capital of Orion Medical Supplies Ltd ("ORION") of the United Kingdom.
Utah Medical Products' (UTMD) Femcare subsidiary said Monday that it has acquired UK-based Orion Med
This is the newest page. Registered accounts read further back.